Lesley Fallowfield
#41,229
Most Influential Person Now
British cancer psychologist
Lesley Fallowfield's AcademicInfluence.com Rankings
Download Badge
Psychology
Lesley Fallowfield's Degrees
- Bachelors Psychology University of Sussex
- PhD Psychology University of Sussex
Similar Degrees You Can Earn
Why Is Lesley Fallowfield Influential?
(Suggest an Edit or Addition)According to Wikipedia, Professor Dame Lesley Jean Fallowfield DBE is a British cancer psychologist and a professor of psycho-oncology at the University of Sussex. The main outcomes of her research have been the establishment of assessment tools to measure quality of life in clinical trials of cancer patients and the design of educational programmes to improve oncologists' communication with their patients.
Lesley Fallowfield's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. (2004) (1787)
- Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. (2006) (1507)
- Communicating sad, bad, and difficult news in medicine (2004) (933)
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial (2007) (836)
- Information needs of patients with cancer: results from a large study in UK cancer centres (2001) (835)
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)† (2018) (820)
- Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial (2002) (816)
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). (2009) (790)
- Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. (1990) (785)
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial (2016) (748)
- Psychiatric morbidity and its recognition by doctors in patients with cancer (2001) (710)
- 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). (2017) (661)
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)† (2014) (566)
- Multidisciplinary teams in cancer care: are they effective in the UK? (2006) (565)
- Effective communication skills are the key to good cancer care. (1999) (531)
- 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) (529)
- Truth may hurt but deceit hurts more: communication in palliative care (2002) (485)
- Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer (2006) (475)
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (445)
- OVARIAN CANCER (2016) (439)
- Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. (2016) (424)
- Doctor-patient interactions in oncology. (1996) (419)
- 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) (2017) (405)
- Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. (1998) (367)
- Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. (1986) (347)
- Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues (2003) (347)
- Enduring impact of communication skills training: results of a 12-month follow-up (2003) (342)
- 1st International consensus guidelines for advanced breast cancer (ABC 1). (2012) (308)
- The quality of life : the missing measurement in health care (1991) (300)
- Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B (1999) (297)
- Giving sad and bad news (1993) (295)
- Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. (2004) (295)
- Rasch fit statistics and sample size considerations for polytomous data (2008) (293)
- Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy (2000) (286)
- The Sexual Activity Questionnaire: A measure of women's sexual functioning (1996) (277)
- Addressing overtreatment of screen detected DCIS; the LORIS trial. (2015) (263)
- No news is not good news: Information preferences of patients with cancer (1995) (262)
- Intentional and non-intentional non-adherence to medication amongst breast cancer patients. (2005) (251)
- Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study (2004) (250)
- Can communication skills training alter physicians' beliefs and behavior in clinics? (2002) (249)
- Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? (1994) (245)
- Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy (2007) (243)
- Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer (2006) (226)
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy (2009) (226)
- Psychological effects of being offered choice of surgery for breast cancer (1994) (219)
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (215)
- Missing quality of life data in cancer clinical trials: serious problems and challenges. (1998) (210)
- Information needs and experiences: an audit of UK cancer patients. (2006) (209)
- 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). (2016) (208)
- Lay understanding of terms used in cancer consultations (2003) (196)
- Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone (1991) (192)
- Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. (2010) (191)
- Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? (1999) (189)
- Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. (2006) (187)
- Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. (2011) (180)
- Factors affecting patient and clinician satisfaction with the clinical consultation: Can communication skills training for clinicians improve satisfaction? (2003) (179)
- Second international consensus guidelines for breast cancer in young women (BCY2). (2014) (179)
- Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. (2008) (177)
- Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study. (2013) (175)
- Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. (2006) (168)
- Systematic review of supportive care needs in patients with primary malignant brain tumors. (2012) (164)
- Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2015) (164)
- Teaching Senior Nurses How to Teach Communication Skills in Oncology (2001) (163)
- The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively (2001) (158)
- Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial (2021) (158)
- Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. (2014) (158)
- Psychosocial and supportive-care needs in high-grade glioma. (2008) (157)
- Getting it taped: the 'bad news' consultation with cancer patients. (1989) (150)
- The effects of hormone therapy on cognition in breast cancer (2003) (139)
- Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study (2008) (138)
- Challenges, solutions and future directions in the evaluation of service innovations in health care and public health (2016) (134)
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012) (130)
- The Medical Interaction Process System (MIPS): an instrument for analysing interviews of oncologists and patients with cancer. (2000) (129)
- Pain outcomes in patients with advanced breast cancer and bone metastases (2013) (129)
- Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study. (2014) (129)
- What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. (2011) (128)
- Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. (2010) (127)
- Quality of Life Measurements in Patients with Malignant Disease: A Review (1986) (125)
- Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. (2001) (124)
- Attitudes of patients to randomised clinical trials of cancer therapy. (1998) (123)
- Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial (2019) (123)
- Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial (2019) (123)
- Clinicians' attitudes to clinical trials of cancer therapy. (1997) (121)
- Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy (2002) (121)
- Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study (2001) (116)
- How do doctors explain randomised clinical trials to their patients? (1999) (115)
- Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid (2012) (114)
- Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). (2008) (112)
- Psychosocial/survivorship issues in breast cancer: are we doing better? (2014) (112)
- Quality of life: a new perspective for cancer patients (2002) (111)
- Psychological morbidity in newly referred patients with cancer. (1995) (110)
- The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK (2005) (108)
- Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial (2011) (108)
- Participation of patients in decisions about treatment for cancer (2001) (106)
- The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial. (1995) (104)
- Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. (2005) (100)
- Psychosocial interventions in cancer (1995) (99)
- Are members of multidisciplinary teams in breast cancer aware of each other's informational roles? (2001) (99)
- Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments? (2001) (98)
- What are the Psychological Factors Influencing Attendance, Non-Attendance and Re-Attendance at a Breast Screening Centre? (1990) (98)
- Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review (2015) (95)
- Psychosocial adjustment after treatment for early breast cancer. (1990) (91)
- Sentinel lymph node biopsy in patients with multifocal breast cancer. (2004) (91)
- 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) (2016) (88)
- Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives (2020) (87)
- Communication and informed consent in phase 1 trials: a review of the literature (2006) (86)
- ARIX: a randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. (2013) (86)
- Counselling and communication in health care (1991) (86)
- Psychosexual function and impact of gynaecological cancer. (2007) (86)
- Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme (2005) (85)
- International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. (2013) (84)
- Offering choice of surgical treatment to women with breast cancer. (1997) (83)
- Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (2013) (81)
- The influence of audiotapes on patient participation in the cancer consultation. (1995) (80)
- The attitudes of 1066 patients with cancer towards participation in randomised clinical trials (2010) (79)
- Drivers and barriers to patient participation in RCTs (2013) (78)
- Epoetin alfa improves quality of life in patients with cancer (2004) (78)
- The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ. (2015) (76)
- NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer (2014) (75)
- A question of choice: results of a prospective 3-year follow-up study of women with breast cancer (1994) (75)
- Information preferences of patients with cancer (1994) (74)
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). (2014) (73)
- Psychosocial and sexual impact of diagnosis and treatment of breast cancer. (1991) (72)
- Sentinel lymph node biopsy in male breast cancer patients. (2004) (72)
- Can we improve the professional and personal fulfillment of doctors in cancer medicine? (1995) (72)
- Quality of quality-of-life data (1996) (71)
- Reasons given by patients for participating, or not, in Phase 1 cancer trials. (2011) (68)
- Treatment decision-making in breast cancer: the patient–doctor relationship (2008) (68)
- Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. (2001) (68)
- Offering choice of treatment to patients with cancers. A review based on a symposium held at the 10th annual conference of The British Psychosocial Oncology Group, December 1993. (1995) (65)
- A Rasch and confirmatory factor analysis of the General Health Questionnaire (GHQ) - 12 (2010) (65)
- Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. (2004) (65)
- Assessment of quality of life in breast cancer. (1995) (62)
- A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. (2003) (61)
- The value of progression-free survival to patients with advanced-stage cancer (2012) (60)
- Current concepts of communication skills training in oncology. (2006) (60)
- Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases (2015) (59)
- The treatment of early breast cancer in women over the age of 70 (2011) (58)
- The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer. (2010) (57)
- Psychological outcomes in women with early breast cancer. (1990) (57)
- Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial (2007) (55)
- Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disorders (1999) (52)
- Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase? (2011) (51)
- Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? (2005) (49)
- Addressing the Psychological Needs of the Conservatively Treated Breast Cancer Patient: Discussion Paper (1987) (49)
- Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review (2016) (48)
- Acceptance of adjuvant therapy and quality of life issues. (2005) (47)
- A daily diary for quality of life measurement in advanced breast cancer trials. (1993) (47)
- Patient-reported outcome measures for cancer caregivers: a systematic review (2016) (46)
- Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer. (2004) (46)
- Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials (2011) (45)
- Describing randomisation: patients' and the public's preferences compared with clinicians' practice (2002) (45)
- Pulmonary metastasectomy in colorectal cancer: time for a trial. (2009) (45)
- Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update (2021) (45)
- Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation (2012) (45)
- When Breast Cancer Recurs: A 3‐Year Prospective Study of Psychological Morbidity (1996) (43)
- Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. (1999) (43)
- Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making (2013) (42)
- The pervasive nature of uncertainty—a qualitative study of patients with advanced cancer and their informal caregivers (2017) (42)
- Clinicians’ attitudes towards clinical trials of cancer therapy (2011) (42)
- Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study (2017) (42)
- The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. (2002) (42)
- Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study. (2001) (42)
- Do psychological studies upset patients? (1987) (41)
- Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. (1993) (41)
- Psychological morbidity associated with ovarian cancer screening: results from more than 23 000 women in the randomised trial of ovarian cancer screening (UKCTOCS) (2014) (40)
- Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. (2017) (40)
- Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making. (2013) (40)
- Metastatic breast cancer. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force. (2007) (40)
- After going through chemotherapy I can't see another needle. (2007) (40)
- Evolution of breast cancer treatments: current options and quality-of-life considerations. (2004) (39)
- The effects of oestrogens and anti-oestrogens on cognition. (2001) (39)
- Counselling for patients with cancer. (1988) (38)
- questionnaires and semistructured interviews mastectomy : prospective study using The psychosocial impact of bilateral prophylactic (2001) (38)
- Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents (2015) (36)
- Selective loss of chromatic sensitivity in demyelinating disease. (1984) (36)
- Psychological outcome of treatment for early breast cancer: A review (1989) (36)
- The use of denial in an ethnically diverse British cancer population: a cross-sectional study (2005) (35)
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. (2022) (35)
- Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study (2004) (35)
- Behavioural interventions and psychological aspects of care during chemotherapy. (1992) (35)
- The ideal consultation. (1992) (35)
- Quality of life measurement in breast cancer. (1993) (33)
- Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening (2010) (33)
- Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer (2007) (33)
- Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. (2012) (32)
- The Pulmonary Metastasectomy in Colorectal Cancer cohort study: Analysis of case selection, risk factors and survival in a prospective observational study of 512 patients (2021) (32)
- Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition? (2007) (30)
- Evaluation of an educational program to improve communication with patients about early-phase trial participation. (2012) (30)
- Group Acupuncture to Relieve Radiation Induced Xerostomia: A Feasibility Study (2009) (29)
- Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer. (2016) (29)
- Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation (2015) (28)
- Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study (2013) (28)
- Patient-reported outcomes in metastatic castration-resistant prostate cancer (2016) (27)
- Treatment Outcomes and Quality of Life (1989) (27)
- Quality of life and patient-reported outcomes in the older breast cancer patient. (2009) (27)
- Assessing the quality of life of postmenopausal women randomized into the ATAC (“arimidex”, tamoxifen, alone or in combination) adjuvant breast cancer trial (2003) (26)
- The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397) (2007) (26)
- Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer. (2005) (26)
- Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009 (2010) (26)
- Things to consider when teaching doctors how to deliver good, bad and sad news (1996) (24)
- Living with metastatic breast cancer: a global patient survey (2010) (24)
- The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2017) (23)
- Psychological Welfare of Patients with Breast Cancer (1989) (23)
- Anxiety in women "at risk' of developing breast cancer. (1996) (22)
- How to improve the communication skills of oncologists. (2000) (22)
- Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2013) (22)
- Cancer counselling in the United Kingdom (1992) (21)
- Patients' decision-making in a UK specialist centre with high mastectomy rates. (2008) (21)
- Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits (2016) (21)
- The psychological consequences of being at risk of developing breast cancer. (1993) (21)
- Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study. (2015) (20)
- Patient-reported outcome measures and the evaluation of services (2016) (20)
- POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes (2018) (20)
- Introducing new treatments for cancer : Edited by C.J. Williams. Chichester: Wiley, 1992. Price £49.95. 492 pp. (1993) (20)
- Low grade Ductal Carcinoma in situ (DCIS): how best to describe it? (2014) (19)
- What non-prescription treatments do UK women with breast cancer use? (2006) (19)
- Communication skills training for breast cancer teams talking about trials. (2014) (19)
- Delivering bad news in gastroenterology. (1994) (19)
- Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts) with metastatic breast cancer: Results from a phase III clinical trial. (2010) (19)
- Long-Term Follow-Up of the Intergroup Exemestane Study. (2017) (18)
- Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability (2011) (18)
- Pulmonary metastasectomy in colorectal cancer: health utility scores by EQ-5D-3L in a randomized controlled trial show no benefit from lung metastasectomy (2020) (18)
- Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]. (2017) (18)
- Communication with Patients after Errors (2010) (18)
- Helping the relatives of patients with cancer. (1995) (18)
- The myth of pulmonary metastasectomy (2020) (18)
- Quality of life issues in relation to the aromatase inhibitor (2007) (18)
- The impact of endocrine therapy on patients with breast cancer: a review of the literature. (2002) (17)
- Quality of life assessment using patient-reported outcome (PRO) measures: still a Cinderella outcome? (2018) (17)
- Sentinel node biopsy in breast cancer: The first results of the randomized multicenter ALMANAC Trial (2004) (17)
- A UK-wide survey of follow-up practices for patients with high-grade glioma treated with radical intent. (2011) (17)
- Patient-physician interactions during early breast-cancer treatment: results from an international online survey. (2008) (17)
- Teams Talking Trials: results of an RCT to improve the communication of cancer teams about treatment trials. (2013) (17)
- There's many a slip twixt cup and lip: adherence issues in cancer therapy (2008) (16)
- Sexual functioning in 4,418 postmenopausal women participating in UKCTOCS: a qualitative free-text analysis (2019) (16)
- Five-year quality of life (QOL) follow-up of adjuvant endocrine therapy for postmenopausal women in the Arimidex (A), Tamoxifen (T), Alone or in Combination (ATAC) Trial (2005) (16)
- Time for a low-risk DCIS trial: harnessing public and patient involvement. (2012) (16)
- Learning how to communicate in cancer settings (2005) (16)
- Information provision for patients by breast cancer teams about the side-effects of hormone treatments. (2006) (16)
- Effects of denosumab versus zoledronic acid (ZA) on health-related quality of life (HRQL) in metastatic breast cancer: Results from a randomized phase III trial. (2010) (15)
- 1091 PAIN OUTCOMES IN PATIENTS WITH BONE METASTASES FROM CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM A PHASE 3 TRIAL OF DENOSUMAB VS. ZOLEDRONIC ACID (2011) (15)
- Communication skills of oncologists (1998) (15)
- Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases (2012) (15)
- Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. (2012) (15)
- Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial. (2017) (15)
- Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ (2013) (14)
- Sun-protective behaviors in families at increased risk of melanoma. (2007) (14)
- Who supports the cancer counsellors? (1990) (14)
- Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. (2019) (14)
- Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2020) (14)
- Has Psychosocial Oncology Helped in the Management of Women with Breast Cancer? (1996) (14)
- Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomized Controlled Trial (2016) (14)
- Counselling and communication in oncology. (1991) (14)
- Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones (2006) (13)
- Patient–physician interactions during early breast-cancer treatment: results from an international online survey (2008) (13)
- Delivering Sad or Bad News (1995) (13)
- The preferences of 600 patients for different descriptions of randomisation (2005) (13)
- Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts) with advanced cancer (excluding breast and prostate) or multiple myeloma (MM): Results from a randomized phase III clinical trial. (2010) (12)
- 6.1 Communication with the patient and family in palliative medicine (2009) (12)
- Blurring of boundaries in the doctor-patient relationship. (2014) (11)
- Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups. (1998) (11)
- Enhancing decision‐making about adjuvant chemotherapy in early breast cancer following EndoPredict testing (2018) (11)
- The preferences and experiences of different bisphosphonate treatments in women with breast cancer (2011) (11)
- Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population- Based Cohort Study (2016) (11)
- Measurement of quality of life in advanced breast cancer. (1990) (11)
- Effect of early American results on patients in a tamoxifen prevention trial (IBIS) (1998) (11)
- Quality of Life in the Elderly Woman with Breast Cancer Treated with Tamoxifen and Surgery or Tamoxifen Alone (1994) (11)
- Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening (2015) (10)
- Early discharge after surgery for breast cancer (1998) (10)
- Mastectomy or conservation: the patient's choice. (1988) (10)
- Overtreatment of Low-Grade Ductal Carcinoma In Situ. (2016) (10)
- The challenge of interacting with patients in oncology. (2009) (10)
- Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey. (2008) (10)
- Counselling and communication in health careCounselling and communication in health care Wiley John £ 15.95 358pp 0-471-92965-4 (1991) (10)
- Questionnaire design. (1995) (10)
- Under-reporting of symptoms in patients with early breast cancer (EBC) who have received tamoxifen treatment for 2–3 years (abstract 48) (2003) (10)
- The need to determine whether lung metastasectomy improves survival in advanced colorectal cancer (2014) (10)
- The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study (2011) (9)
- Denosumab or zoledronic acid (ZA) therapy on pain interference and cancer-specific quality of life (CSQoL) in patients with castrate-resistant prostate cancer (CRPC) and bone metastases (BM). (2014) (9)
- A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer (2020) (9)
- Development and validation of the patient roles and responsibilities scale in cancer patients (2018) (9)
- NICE Guidelines: management of colorectal cancer metastases (2020) (9)
- Treatment Experiences, Information Needs, Pain and Quality of Life in Men with Metastatic Castrate-resistant Prostate Cancer: Results from the EXTREQOL Study. (2019) (9)
- Measuring the Quality of Life in Breast Cancer (1994) (8)
- 165MO Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study (2020) (8)
- Development and validation of the caregiver roles and responsibilities scale in cancer caregivers (2019) (8)
- Abstract P4-12-11: Patient preference for subcutaneous trastuzumab via handheld syringe versus intravenous infusion in HER2-positive early breast cancer: Cohort 2 of the PrefHer study (2013) (8)
- Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy. (2013) (8)
- Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study (2018) (8)
- Quality of life assessment in patients with heart disease. (1993) (8)
- Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study. (2021) (8)
- Acronymic trials: the good, the bad, and the coercive (2002) (7)
- The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality: a pilot study (2001) (7)
- Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial (2017) (7)
- Supportive follow-up in patients treated with radical intent for high-grade glioma. (2012) (7)
- Group recruitment sessions enhance patient understanding in a small multi-centre phase III clinical trial. (2012) (7)
- P155 Anastrozole and letrozole – an investigation and comparison of quality of life, tolerability and morbidity (2007) (7)
- For the Benefit of Others: Reasons Why Women with Breast Cancer Participate in RCTs (2015) (7)
- Quality of survival: a new concept framework to assess the quality of prolonged life in cancer (2017) (7)
- Contraceptive use by women receiving chemotherapy for breast cancer (1998) (7)
- No man’s land: information needs and resources of men with metastatic castrate resistant prostate cancer (2016) (7)
- 99 The impact of bone metastases on pain: Results from a phase III denosumab study in men with nonmetastatic castration-resistant prostate cancer (2013) (7)
- Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians (2019) (6)
- Sexuality in women receiving chemotherapy for breast cancer. (1997) (6)
- Preferences of hxealthy men for two different endocrine treatment options offered for locally advanced prostate cancer* (2005) (6)
- Specialist breast care and research nurses' attitudes to adjuvant chemotherapy in older women with breast cancer. (2012) (6)
- The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT (2017) (6)
- Preliminary results from the IBISII (prevention) cognitive sub-protocol. (2006) (6)
- Sexual Dysfunction in Breast Cancer Survivors: Cross-Cultural Adaptation of the Sexual Activity Questionnaire for Use in Portugal. (2016) (5)
- Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group (1999) (5)
- Psychosocial aspects of risk appraisal (2008) (5)
- Too Hot, Too Cold or Can We Get it Just Right? What Emotional Distance Should Oncologists Keep from their Patients? (2017) (5)
- Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. (2019) (5)
- Evaluation of Counselling in the National Health Service (1993) (4)
- Quality of life assessments may help some patients (1998) (4)
- Positive epoetin alfa effect on quality of life in anemic cancer patients receiving chemotherapy: results from a randomized placebo-controlled trial (1999) (4)
- Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy* (2005) (4)
- Survey of the attitudes to and use of quality of life measures by breast cancer specialists in the UK (1996) (4)
- Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance (2021) (4)
- Quality of life in breast cancer--results from 3 cancer research campaign studies. (1993) (4)
- 711 EFFECTS OF DENOSUMAB AND ZOLEDRONIC ACID ON PAIN INTERFERENCE WITH DAILY FUNCTIONING IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER (2011) (4)
- Sentinel node biopsy in breast cancer: The first results of the randomized multicenter ALMANAC Trial. (2004) (4)
- A new paradigm or a misrepresentation of current communication research and teaching? (2017) (4)
- Effects of Standard Treatments for Ductal Carcinoma In Situ-Making Informed Choices. (2016) (4)
- Weighing bone-targeted treatment options for patients with solid tumours and skeletal complications from metastatic disease (2012) (4)
- Patient/oncologist decisions about adjuvant chemotherapy in ER+ve, HER2-ve early breast cancer following endopredict testing. (2017) (4)
- Quality of life issues during adjuvant endocrine therapy. (2009) (4)
- What is newsworthy? (2002) (4)
- Abstract P1-13-05: The Effect of Treatment with Denosumab or Zoledronic Acid on Health-Related Quality of Life in Patients with Metastatic Breast Cancer (2010) (4)
- Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing (2020) (4)
- The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort (2021) (4)
- THE ROLE OF PATIENT REPORTED OUTCOMES (2015) (4)
- The cost-effectiveness of EndoPredict to inform adjuvant chemotherapy decisions in early breast cancer (2019) (4)
- Clinical trials to real life: the relevance of quality of life (2000) (3)
- Importance of Providing Tailored Resources to Patients with Metastatic Breast Cancer: Results of the Global BRIDGE Survey (2009) (3)
- POSNOC: Positive sentinel node—Adjuvant therapy alone versus adjuvant therapy plus clearance or axillary radiotherapy: A randomised trial looking at axillary treatment in early breast cancer (ISRCTN54765244). (2015) (3)
- Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2021) (3)
- Controversy over mammographic screening. (1988) (3)
- 177PEffects of neratinib (N) on health-related quality of life (HRQoL) in early-stage HER2+ breast cancer (BC): longitudinal analyses from the phase III ExteNET trial (2017) (3)
- 0203 Evaluating the needs of women living with metastatic breast cancer: A global survey (2009) (3)
- 943 PAIN INTERFERENCE WITH DAILY FUNCTIONING IN PATIENTS WITH CASTRATE-RESISTANT PROSTATE CANCER: A COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID (2012) (3)
- Abstract P2-12-11: Does goserelin have an effect on quality of life in women who have chemotherapy for early breast cancer? Results from the OPTION randomised trial (2020) (3)
- Entry into the tamoxifen prevention trial depends on women's estimates of the population risk of breast cancer (1995) (3)
- Discussing expensive anti-cancer drugs (2011) (3)
- Psychosocial Implications of Prophylactic Bilateral Mastectomy (1998) (3)
- ARIX: A randomized trial of acupuncture versus oral care sessions in patients with chronic radiation-induced xerostomia following treatment for head and neck cancer. (2012) (3)
- What should women do in the meantime? (2011) (3)
- Challenging Cancer. From Chaos to Control (1992) (3)
- P4-13-01: Pain Severity and Analgesic Use Associated with Skeletal-Related Events in Patients with Advanced Breast Cancer and Bone Metastases. (2011) (3)
- Communication and counselling needs of patients with lymphoma. (1994) (3)
- 74 Development of a structured yoga DVD for women following breast and axillary surgery (2010) (2)
- Abstract P5-16-03: The impact of skeletal-related events on pain interference in patients with advanced breast cancer and bone metastases (2015) (2)
- 3331 Quality of survival (QoS) concept framework to assess the quality of prolonged life in advanced melanoma (MEL): Principles and application related to treatment with nivolumab (NIVO) (2015) (2)
- A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot (2022) (2)
- Cancer study controversy (1994) (2)
- Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC): a multi-centre randomized clinical trial (2019) (2)
- RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer (2017) (2)
- An online review of informational sources for advanced or high-risk cutaneous squamous cell carcinoma (2021) (2)
- [Abstract] Surveying patients’ views on trial information provision and decision making using the ‘Accept/Decline’ clinical trials questionnaire (2017) (2)
- Psychophysical assessment of a patient with Tolosa-Hunt syndrome. (1983) (2)
- Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (2014) (2)
- The Psychological Impact of Breast Cancer (2010) (2)
- Uncertainty about the future for patients with advanced cancer and their informal caregivers: A qualitative view. (2017) (2)
- British Psychological Oncology Group: seventh annual conference. (1992) (2)
- Abstract P2-12-16: Exploratory post hoc analyses of patient-reported outcomes (PROs) in the IMELDA randomized phase III trial: Maintenance bevacizumab (BEV) ± capecitabine (CAP) after initial first-line BEV plus docetaxel (DOC) for HER2-negative metastatic breast can (2015) (2)
- Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer (2007) (2)
- Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors' (2008) (2)
- The design of advanced breast cancer trials. New approaches. (1990) (2)
- P126 Routes of administration in breast cancer:Preliminary findings from a patient survey (2005) (2)
- Effect of denosumab versus zoledronic acid on health-related quality of life in patients with metastatic breast cancer. (2011) (2)
- Psychological Aspects of Malignant Melanoma (1992) (2)
- Sensitivity and Specificity of Multimodal and Ultrasound Screening for Ovarian Cancer, and Stage Distribution of Detected Cancers: Results of the Prevalence Screen of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (2009) (2)
- The Medical Interaction Process System (MIPS)—an instrument for analysing videotaped interviews of oncologists and patients with cancer (1998) (1)
- Book Review: Dianne Berry, Health Communication: Theory and Practice (2008) (1)
- Evaluation of an intervention to improve communication about phase I/II trials. (2011) (1)
- 1125PThe cost-effectiveness of EndoPredict to inform adjuvant chemotherapy decisions in early breast cancer (2017) (1)
- UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis (2020) (1)
- 220 Internal Barriers to Effective Care (Staff Dynamics) (2012) (1)
- The Prospective Observational Cohort and the Nested Randomized Controlled Trial in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC Study) Question the Reliance on Existing Evidence for the Magnitude of Benefit From Lung Metastasectomy. (2021) (1)
- Do patients regard hormone therapy received in early breast cancer as worthwhile (1999) (1)
- Talking about difficult things in cancer: Do we achieve what patients need? (2002) (1)
- The fallacy of large survival gains from lung metastasectomy in colorectal cancer (2021) (1)
- Canoncologists detect distress intheir out-patients andhowsatisfied are theywiththeir performance during badnewsconsultations? (1994) (1)
- Abstract P1-09-05: The RAZOR trial: a phase II prevention trial of screening plus goserilin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer. (2012) (1)
- A structured review of quality of life in advanced and high‐risk cutaneous squamous cell carcinoma shows the need for more studies and better measures (2021) (1)
- 7004 ORAL Pain Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab Vs Zoledronic Acid (ZA) in Patients With Solid Tumours and Bone Metastases (2011) (1)
- 46. Understanding of prognosis on the psychological impact of recurrent breast cancer (1995) (1)
- Doctors' communication of trust, care, and respect (2004) (1)
- MP78-01 THE BURDEN OF SKELETAL-RELATED EVENTS ON PAIN OUTCOMES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (2014) (1)
- Exercise levels and experiences of those attending CUFITTER - a tailored exercise programme for people in cancer recovery (2017) (1)
- Abstract P5-13-07: Hormone Levels in the OPTION Trial Show No Ovarian Protection by Goserelin in Adjuvant Chemotherapy for Early Breast Cancer -- An Anglo-Celtic Collaborative Group and NCRN Trial (2010) (1)
- The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial. (2020) (1)
- Reasons why patients accept or decline entry to randomised clinical trials of cancer therapy (1999) (1)
- 45. The psychological impact of recurrence of breast cancer (1995) (1)
- Hope and quality of life (2001) (1)
- Patient's view of minimum acceptable benefits from adjuvant hormonal therapy (2000) (1)
- Abstract OT1-03-01: The UK LORIS trial: Randomizing patients with low or low intermediate grade ductal carcinoma in situ (DCIS) to surgery or active monitoring (2017) (1)
- [Behavioral interventions and psychological aspects of care during chemotherapy]. (1993) (1)
- The Low Randomisation Rate in a Trial of Lung Metastasectomy Was More Often Due to Failure of Clinical Equipoise Rather Than Patients' Unwillingness to Be Randomised (2020) (1)
- Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar (2020) (1)
- 362 INVITED Identification and Management of Treatment-Related Symptoms for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy (2011) (1)
- 80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study (2020) (1)
- Corrigendum to “The effects of hormone therapy on cognition in breast cancer” [J. Steroid Biochem. Mol. Biol. 86 (2003) 405–412] (2005) (1)
- 1534 Patients' understanding about the therapeutic aims of novel drugs shown only to offer PFS benefit (2015) (0)
- 189PEnhancing decision-making about adjuvant chemotherapy in ER+, HER2- early breast cancer (EBC) following EndoPredict testing (2017) (0)
- Abstract P1-11-03: Breast cancer trial design may influence recruitment to RCTs (2013) (0)
- IN10 THE ROLE OF PATIENT REPORTED OUTCOMES (2015) (0)
- Reply to P.F. Pinsky, C.P. Crum, and M.W. McIntosh et al. (2016) (0)
- Psychosocial issues in breast cancer (2019) (0)
- Impact of skeletal-related events on pain and analgesic use in patients with solid tumors and bone metastases. (2013) (0)
- Breast cancer prognosis expressed as "chance of cure" is preferable to "10 year survival" (1998) (0)
- What's in a name: Describing ductal carcinoma in situ (DCIS). (2014) (0)
- 9 The balance of endocrine therapy, symptom burden and outcomes for cancer survivors (2009) (0)
- Talking to patients about clinical trial entry from phase I to phase III (2011) (0)
- Guidelines either omit important aspects of care and follow-up or are based on assumptions with (2012) (0)
- OP-ANNO180192 1634..1657 (2018) (0)
- The communication challenges during patient-centred decision-making (2017) (0)
- Anxiety inwomen'atrisk' ofdeveloping breast cancer (1996) (0)
- IMPLEMENTING PROMS IN CLINICAL RESEARCH AND CLINICAL PRACTICE (2019) (0)
- Measuring the impact of extended cancer survival on broader aspects of life and wellbeing: The PROACT Study. (2017) (0)
- Do drugs that offer PFS or modest OS benefits improve quality of life in patients with advanced cancer (2017) (0)
- Current Concepts: Pulmonary Metastasectomy for Colorectal cancer (2010) (0)
- Cancer and the family, L. Baider, C.L. Cooper, A.K. De-Nour (Eds.). Wiley, Chichester (1996), 414, ISBN: 0-471-95890-5 (1997) (0)
- 0-44. Are we using the right questionnaires when screening for anxiety and depression in women with early breast cancer? (1997) (0)
- Book Review: Challenging Cancer. From Chaos to Control (1992) (0)
- The ADVOCATE study (Advanced Ovarian Cancer: Care & Treatment Experiences) (2013) (0)
- Abstract P5-01-07: Recruitment, clinical equipoise, patient acceptance and compliance in the UK-ANZ POSNOC trial (2023) (0)
- Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study (2016) (0)
- The views of patients and the general public about expensive non-funded anti - cancer drugs in the NHS (2011) (0)
- WITHDRAWN: A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. (2008) (0)
- 0131 Survival & safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment: A number needed to treat analysis based on the intergroup exemestane study (IES) (2009) (0)
- Measuring outcomes from adjuvant hormone therapy: the patients' view of the minimum acceptable benefit from treatment (2001) (0)
- Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING): development and evaluation of an educational programme for healthcare professionals about BRCA1 & BRCA2 testing (2022) (0)
- 88. Now or never? Breast reconstruction and psychological adjustment to breast cancer (1995) (0)
- E19. Patient communication (2010) (0)
- Cancer patient care: Psychosocial treatment methods, M. Watson. Cambridge University Press, Leicester (1991), (hard cover); 0-521-42631-6 (paper cover), ISBN: 0-521-41632-9 (1995) (0)
- Book reviewISBN 1-85343-369-1 Breast cancer: A pyschological treatment manual, S. Haber (Ed.), Free Association Books (1997), p. 178 (1997) (0)
- Can training in communication make doctors' interactions more patient-centred? (2002) (0)
- Abstract OT3-03-02: Maximising recruitment and retention of patients into UK-ANZ POSNOC trial (2017) (0)
- C a n Communication S kills T raining A lter P hysicians' Beliefs a nd B ehavior i n C linics? (2011) (0)
- Abstract P5-15-04: An intervention to help improve understanding of gene expression profiling tests in breast cancer: which is best, an information film or leaflet? (2022) (0)
- Differences on side effects assessment among doctors, nurses and patients (2011) (0)
- Exploring the use of information films to improve patient understanding of genomic expression profiling (GEP) tests in the breast cancer setting (2022) (0)
- Abstract P6-14-01: Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st-line BEV therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC) (2016) (0)
- The Friendly Professional: Selected Writings of Thurstan Brewin (1996) (0)
- Abstract ES9-1: Discussing risk & uncertainty with patients in the context of GEP testing (2020) (0)
- [Rapid response] Re: colorectal cancer: summary of NICE guidance (2020) (0)
- Abstract P2-14-09: Results from a novel educational program to help nurses when discussing the Oncotype DX Breast Recurrence Score® with their patients (2020) (0)
- Abstract PL03: Psychosocial, survivorship issues: Are we doing better? (2013) (0)
- End of Life (EOL) Communication – The Healthcare Provider Perspective (2017) (0)
- CMF versus epirubicin in advanced breast cancer: Validating a new QoL tool (1992) (0)
- SERIAL CA125 CAN DETECT OVARIAN CANCER IN THE ABSENCE OF ULTRASOUND ABNORMALITIES (2014) (0)
- Psychosocial impact of endocrine therapy for breast cancer on women's quality of life (1998) (0)
- Strategies for Communicating Treatment Risks and Uncertainty of Outcomes (2018) (0)
- Psychosocial compliance and response rates in a chemoprevention randomised control trial of women at high risk to breast cancer (1998) (0)
- Patient-physician interactions during early breast-cancer treatment: results from an international online survey (2008) (0)
- 0-26. Psychosocial implications of prophylactic bilateral mastectomy (1997) (0)
- Do we know if patients value Progression Free Survival (2017) (0)
- Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study) (2022) (0)
- IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer (2021) (0)
- Abstract P4-11-04: Talking about risk in the context of GEomic profiling tests (TARGET) (2018) (0)
- 'The sooner the better' or 'too much too soon'? A pilot prospective longitudinal study to evaluate quality of life and body image following immediate latissimus dorsi breast reconstruction (2008) (0)
- 1012 - Training oncologists in communication (1997) (0)
- 156TiP BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast cancer (2022) (0)
- Psychological outcomesofdifferent treatment policies inwomen with early breast canceroutside aclinical trial (1990) (0)
- Pain Interference Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab vs Zoledronic Acid (ZA) in Patients with Solid Tumors and Bone Metastases (2012) (0)
- Communication and patient comprehension of phase 1 oncology trials: Results of a pilot study (2007) (0)
- Patients’ expectations and experiences of abemaciclib and hormone therapy for early-stage high-risk breast cancer (2021) (0)
- 1348 Practical issues concerning quality of life from design to interpretation (1995) (0)
- The prince and the professor: Heretics unite (2004) (0)
- Author's response to reviews Title: Impact On Mortality And Cancer Incidence Rates Of Using Random Invitation From Population Registers For Recruitment To Trials Authors: (2011) (0)
- Abstract OT3-08-01: Interview data from women contemplating LORIS trial entry during the feasibility study (2018) (0)
- COLORECTAL CANCER: A CAUTIONARY TALE The need to determine whether lung metastasectomy improves survival in advanced colorectal cancer (2014) (0)
- 323PPATIENT SATISFACTION WITH SELF-ADMINISTRATION OF SUBCUTANEOUS (SC) TRASTUZUMAB VIA SINGLE-USE INJECTION DEVICE (SID) IN THE INTERNATIONAL, RANDOMISED PREFHER STUDY. (2014) (0)
- 1509 Oncologists' decision making about novel therapies for patients with metastatic disease (2015) (0)
- How heretical thoughts and challenging orthodoxy improves breast cancer care (2019) (0)
- Cancer and stress, C.L. Cooper, M. Watson (Eds.). Wiley, Madison, WI (1991) (1992) (0)
- Efficacy of an intervention to improve communication about randomised clinical trials (RCTS) in cancer. (2004) (0)
- Does treatment for breast cancer affect cognition? A pilot study using a pragmatic cognitive assessment package (2003) (0)
- 1542 Gaps and inconsistencies found in information available for men with mCRPC (2015) (0)
- 219P UK survey measuring informational needs & QoL in women living with metastatic breast cancer (LIMBER) (2022) (0)
- IN23 PSYCHOLOGICAL SUPPORT: WHEN AND HOW (2013) (0)
- Talking about risk in the context of genomic tests (TARGET): Evaluation of an educational program. (2019) (0)
- Patient evaluation of hormone therapy in breast cancer: Quantifying trade-offs between survival gains and quality of life (1998) (0)
- SY-9-2 Communication between Breast Cancer Patients and Physicians (1996) (0)
- Breast cancer: A pyschological treatment manual, S. Haber (Ed.). Free Association Books (1997), 178, ISBN 1-85343-369-1 (1997) (0)
- Conclusion and New Directions (2002) (0)
- eMonarcHER: A phase 3 study of abemaciclib plus standard adjuvant endocrine therapy in patients with HR+, HER2+, node-positive, high-risk early breast cancer. (2021) (0)
- Tamoxifen f or t he P revention o f B reast C ancer: Psychosocial I mpact o n W omen P articipating i n T wo Randomized C ontrolled T rials (2001) (0)
- British Psychosocial Oncology Group: Seventh AnnualConference (1992) (0)
- The cost-effectiveness of screening for ovarian cancer : results from the UK Collaborative Trial of Ovarian Cancer Screening (2017) (0)
- Reporting side effects of adjuvant therapy in breast cancer: Do medical notes reflect patients' self report? (2000) (0)
- 0-30. Sexuality in women receiving chemotherapy for breast cancer (1997) (0)
- 22 Talking with patients about expensive and unavailable new cancer drugs (2009) (0)
- The prince and the professor (2004) (0)
- Adherence to hormone therapy in a chemoprevention randomised trial (2007) (0)
- Do women with breast cancer have differing requirements from hormonal therapy by tablet or injection (2000) (0)
- 99. Psychosocial implications of being ‘at risk’ of developing breast cancer (1995) (0)
- A TIME SERIES ALGORITHM DOUBLES SENSITIVITY OF POPULATION SCREENING FOR OVARIAN CANCER IN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) (2014) (0)
- P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study) (2023) (0)
- Communication in cancer care. Edited by Kathryn Nicholson Perry and Mary Burgess, Blackwell Publishing, Oxford, 2002. £15.99. 156pp (paperback). ISBN: 1-405-10027-3. (2005) (0)
- Communicating the oncotype DX® test results: A novel educational workshop for specialist breast care nurses. (2020) (0)
- Effect of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer (1987) (0)
- The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer (2020) (0)
- Quality of life in elderly women with breast cancer (1992) (0)
- PRM178Evaluation And Validation Of The Proact Measures For Cancer Patients And Informal Caregivers (2017) (0)
- O-31 Anastrozole and letrozole an investigation and comparison of quality of life, tolerability and morbidity (aliquot) – results of the quality of life arm of the study (2007) (0)
- Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial) (2022) (0)
- Report of the british psychosocial oncology group annual conference 1991 (1992) (0)
- PL9.1. The importance of patient reported outcomes (PROs) in determining efficacy of treatment (2008) (0)
- Women prefer breast cancer prognosis expressed as chance of cure to 10-year survival (1998) (0)
- How much improvement in survival do early breast cancer patients require to consider endocrine therapy worthwhile (2001) (0)
- The importance of Communication in Treating Women With Breast Cancer (The Ganz Article Reviewed) (2008) (0)
- The myth of pulmonary metastasectomy (2020) (0)
- Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases (2010) (0)
- Faculty Opinions recommendation of United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer. (2017) (0)
- 1715 Patient reported outcome measures for cancer caregivers: A systematic review (2015) (0)
- Researchand confirmatory factor analysis of the General Health Questionnaire (GHQ) - 12 (2010) (0)
- The development and evaluation of a communication skills programme for health care professionals in oncology (1998) (0)
- Patient satisfaction with communication: a new instrument (1998) (0)
- Author's response to reviews Title: Rasch Fit Statistics and Sample Size Considerations for Polytomous Data Authors: (2008) (0)
- Communication of breast cancer prognosis: Women wish to know their chance of cure (1998) (0)
- Psychosocial controversies in breast cancer (2007) (0)
- Faculty Opinions recommendation of Is it time to reconsider the term "cancer survivor"? (2019) (0)
- Patient Roles and Responsibilities Scale (2019) (0)
- Medicine and Books (1991) (0)
- Communication about sex between health care professionals and patients with ovarian cancer: attitudes and beliefs versus reality (1999) (0)
- Promotion of adaptive coping in cancer (2000) (0)
- Report of the british psychosocial oncology group annual conference 1992 (1993) (0)
- Psychological response to breast cancer and its impact on survival (2004) (0)
This paper list is powered by the following services:
Other Resources About Lesley Fallowfield
What Schools Are Affiliated With Lesley Fallowfield?
Lesley Fallowfield is affiliated with the following schools:
